Manufacturing and marketing medical pharmaceutical for human usage. It exports mainly to Saudi A., Algeria, Iraq, UAE, Romania and other Gulf states, and its exports constitute 70% of its sales.
Incorporated in 1975
It was incorporated as a public shareholding company. It gained the EU-GMP in 2002 to export to the European markets.
Mode of Finance
Its initial paid capital was JD 12 million. The Net Income for the six half months of 2002 was 3.6 million compared to 2.8 million in 2001. The Social Security Corporation shares 8.76% of its capital and the board of directors about 9% and others about 80% as shown in its 2002 auditing. Its investments reached JD 2.3 million in 2001 distributed on the following coorporations: Dar Al-Dawa Algeria(90% of its capital), JORAS Algeria(70%), Nutri Dar(47.5%), AlNahda Financial Investments(40%),
Arab Consulting for Pharmaceutical Manufacturing(36%), Dar Al-Dawa Veterinary(32%). Its sales increased by 24% in 2001 compared to 1999 to reach JD 24 million. Its profits lagged by 7% in 2000 while increased in 2001 with JD 5.2 million. There are 600 workers and the operating and administrative expenses were JD 800 thousand. Its total assets were JD 41 million in 2001.
(last updated: 23-November-2002)
The documentation was gathered with the best efforts of researchers and scholars, in neutral and scientific spirit. We welcome all clarifications, corrections and improvements for best services. A Concept Team makes every effort to ensure, but cannot guarantee, the accuracy at all times of this information. Hyperlinks to or from other websites imply neither responsibility for, nor approval of, the information contained in those websites by A Concept. Copyright A Concept mafhoum "the Arab Decision Makers Project"